Khiron Life Sciences Corp. — Form D
Khiron Life Sciences Corp. of TORONTO, A6, a company, filed a Form D exempt-offering notice with the SEC on 2021-07-20. The offering totals $26.4M, of which $9.9M was reported sold. Industry: Other.
Offering
- Filed: 2021-07-20
- Form: D
- Accession: 0001062993-21-006623
- Industry: Other
- Exemptions: 06b
- Total offering: $26.4M
- Amount sold: $9.9M
- Remaining: $16.5M
- Investors: 4
- Date of first sale: 2021-07-06
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-406919
Issuer
- Name: Khiron Life Sciences Corp.
- CIK: 0001873100
- Entity type: Corporation
- Jurisdiction: BRITISH COLUMBIA, CANADA
- Address: 100 KING STREET WEST, TORONTO, A6, M5X 1G5
- Phone: 403-681-2549
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| Joel Friedman | Director | Bloomfield, MI |
| Tejinder Virk | Director | New Romney, X0 |
| Joel Friedman | Executive Officer | Bloomfield, MI |
| Tejinder Virk | Executive Officer | New Romney, X0 |
| Swapan Kakumanu | Executive Officer | Vancouver, A1 |
| Deborah Rosati | Director | Toronto, A6 |
| Vicente Fox | Director | Toronto, A6 |
| Alvaro Yanez | Director | Toronto, A6 |
| Chris Naprawa | Director | Toronto, A6 |
| Alvaro Torres | Director | Toronto, A6 |
| Alvaro Torres | Executive Officer | Toronto, A6 |
| Juan Carlos Echeverry | Director | Toronto, A6 |
Other filings by this issuer (1)
More